Webinars

WATCH WEBINAR - 07 6월 2022

Accelerating clinical development in China & the US

China and the US are the world’s largest oncology research destinations, and the clinical research bridge between them supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.

WATCH WEBINAR - 20 5월 2022

Development and Regulatory Strategy for US and China

This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers. Additionally, it aims to understand the Evolving U.S. regulatory requirements for diversity in clinical cancer trials.

WATCH WEBINAR - 13 5월 2022

Go/No Go Decisions Based on Early Phase Oncology Trials

Understanding the latest regulatory and clinical developments in the field of Oncology in China, along with discussing the similarities and differences between Chinese oncology market and the overall global market, promote academic exchange and cooperation of the global oncology research and development ecosystem.

WATCH WEBINAR - 22 10월 2021

Driving efficiencies through virtual trial solutions in Asia Pacific

What is driving the acceleration of clinical trials in the Asia Pacific region and what are key considerations to maximise the opportunity for decentralised clinical trials in the future across the region.

WATCH WEBINAR - 13 9월 2021

Accelerating Clinical Trials in Rare Disease - Understanding Asia’s success as a rare disease clinical trial location

This webinar looks at Asia’s rare disease clinical trial landscape, why China is an increasingly attractive location for rare disease trials and critical program strategies to consider.

WATCH WEBINAR - 14 7월 2021

Expedited clinical development strategies for China

A two-part webinar interview and panel discussion with exclusive insights into China’s regulatory environment, the advantages of involving China sites, and strategies to accelerate entry in China.

WATCH WEBINAR - 26 3월 2021

Presented By Katrina Norial at OCT Southeast

아시아 태평양: 임상 시험 프로그램 가속화를 위한 솔루션

OCT Southeast의 Katrina Norial 발표 발표에서 Katrina Norial은 코로나 19 상황에서 임상 시험 연속성을 보장하고 개발 가속화를 위해 지역적 이점을 활용하는 Novotech의 역량을 논의합니다.

WATCH WEBINAR - 21 3월 2021

The benefits of running clinical trials in China

중국에서 임상 시험 시행시의 이점

중국은 생명공학 기업들이 임상 개발을 가속화할 수 있게 하는 중요한 기회를 제공하고 있습니다. 이번 세션에서는 다음 주제를 논의할 예정입니다:
• 중국 생명공학 임상시험의 최신 연구 및 동향
• 중국과 미국 규제 요건의 차이와 생명공학 기업들이 중국 기관을 포함시킴으로써 얻는 이점
• 스폰서와 시험자의 피드백

WATCH WEBINAR - 18 12월 2020

Achieving regulatory milestones & meeting commercial goals

규제 마일스톤 및 사업 목표 달성

업계 전문가들로부터 간소화되고 핵심적인 글로벌 프로그램 전략의 중요성에 대한 설명을 듣고 제품 개발 계획 및 규제 문제에 대한 특별한 통찰력을 얻을 수 있습니다.

WATCH WEBINAR - 23 10월 2020

Managing Global Studies with Regional Partners

In this webinar, you'll learn about 1) Working with specialist CRO partners to maintain speed, flexibility, “fit” and regional expertise, 2) Leveraging technology and gold standard systems to provide integrated global management structure and reporting and 3) Advantages and tradeoffs of different global clinical trial setups.

WATCH WEBINAR - 25 9월 2020

Accelerating Clinical Trials in Australia and Asia – Presented by Steven Roan at OCT USA

Steven Roan breaks down the acceleration of clinical trials in Australia and Asia. The presentation is broken into three main segments. An introduction to Novotech and how Asia-Pacific is handling the COVID-19 pandemic, what Novotech is doing to support companies in these times, and finally talking about the benefits of working in Asia-Pacific for clinical trials.

WATCH WEBINAR - 12 8월 2020

Running First-in-human and Vaccines Studies in Australia

인간대상 최초 임상시험 및 백신 임상시험 수행 장소로서의 호주

호주에서 인간대상 최초 임상시험을 시작하는 데에는, 사전에 미국의 임상시험용 신약 (IND) 승인신청을 할 필요가 없다. 호주에서 수행되는 인체적용 최초 임상시험들은 그 연구의 질이 우수하며, 수집된 결과를 후기 임상시험을 위해 다른 국가들의 규제당국에 제출하여 인정받을 수 있다.

연락처

채용

솔루션

리소스

안내

Location Settings

Asia-Pacific

North America

GLOBAL

Location Settings

Asia-Pacific

North America